University of Michigan Board of Regents, Ann Arbor, has approved four investment for its Michigan Investment in New Technology Startups, a venture capital fund co-managed by the university’s investment office and its Office of Technology Transfer.
Attercor, a therapy company for adrenal disorders, CytoPherx, a manufacturer of medical devices to treat inflammation-based diseases using a cytopheresis system, NanoBio Corp., which focuses on developing products to prevent and treat infectious diseases using nanoemulsion droplets and Tissue Regenerative Systems a bioresorbable…
